Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Assessing the changes in the brain-gut axis after weight loss surgery and their relationship with weight loss and changes in eating behaviors.
Obese women undergoing weight loss surgery will be recruited to participate in the study. These individuals will undergo a screening visit and 4 study visits. The study visits will occur before, and at 1-, 6- and 12 months after the weight loss surgery. Each study visit will include evaluation of brain function (fMRI), anthropometrics, blood and stool samples and eating behaviors questionnaires.
Assessing the changes in the brain-gut axis after weight loss surgery and their relationship with weight loss and changes in eating behaviors.
Obese women undergoing weight loss surgery will be recruited to participate in the study. These subjects will undergo a screening visit and 4 study visits. The study visits will occur before, and at 1-, 6- and 12 months after the weight loss surgery. Each study visit will include evaluation of brain function (fMRI), anthropometrics, blood samples (gut hormones, cytokines, metabolomics ) and stool samples (16S RNA and Metabolomics) and eating behaviors questionnaires (YFAS, TFEQ, food cravings/preferences scales, 3-day food food intake records)
Primary outcomes: weight loss after surgery and changes in eating behaviors scales (YFAS, TFEQ) , metabolomics, appetite related hormones and gut microbiome (16S RNA) Secondary outcomes: changes in brain function (fMRI/MRS), diet (3-day food intake records) and inflammatory markers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bariatric surgery | Procedure | Laparoscopic bariatric surgery including gastric bypass and sleeve gastrectomy |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of excess weight loss at 6 months | Measure of weight loss, it is calculated using the following formula: preoperative weight - weight at the follow-up visit)/(preoperative weight - Ideal body weight *100. Greater values mean greater weight loss (better). | Measured at 6-months after bariatric surgery |
| Percentage of excess weight loss at 12 months | Measure of weight loss, it is calculated using the following formula: preoperative weight - weight at the follow-up visit)/(preoperative weight - Ideal body weight *100. Greater values mean greater weight loss (better). Greater values are better. | Measured at 12-months after bariatric surgery |
| Change in Yale Food Addiction Scale score at 6 months | Yale Food Addiction Scale that is a 25-item measure developed to measure food addiction. Score range: 0 to 7. Higher scores in the scale mean more symptoms resembling food addiction (worse). | Measured at baseline and at 6-months after the bariatric surgery |
| Change in Yale Food Addiction Scale score at 12 months | Yale Food Addiction Scale that is a 25-item measure developed to measure food addiction. Score range: 0 to 7. Higher scores in the scale mean more symptoms resembling food addiction (worse). | Measured at baseline and at 12-months after the bariatric surgery |
| Change in Three-Factor Eating Questionnaire score at 6-months | Three-Factor Eating Questionnaire is a validated scale that is designed to measure 3 dimensions of human eating behavior: cognitive restraint of eating (Factor I), disinhibition (Factor II), and hunger (Factor III). The minimum score for factors I-II-III is therefore 0-0-0, and maximum possible score is 20-16-15. Higher scores in the respective scales are indicative of greater cognitive restraint (better), uncontrolled (worse), or emotional eating (worse). |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Brain function as measured by functional magnetic resonance imaging ( fMRI) at 6 months | Functional brain images will be obtained using established acquisition protocols for resting state and evoked brain responses | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in Brain function as measured by functional magnetic resonance imaging ( fMRI) at 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
We will include obese women undergoing bariatric surgery as part of standard medical care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D050110 | Bariatric Surgery |
| ID | Term |
|---|---|
| D049088 | Bariatrics |
| D000073319 | Obesity Management |
| D013812 | Therapeutics |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Stool samples for 16S RNA analysis
| Measured at baseline and 6-months after the bariatric surgery |
| Change in Three-Factor Eating Questionnaire score at 12-months | Three-Factor Eating Questionnaire is a validated scale that is designed to measure 3 dimensions of human eating behavior: cognitive restraint of eating (Factor I), disinhibition (Factor II), and hunger (Factor III). The minimum score for factors I-II-III is therefore 0-0-0, and maximum possible score is 20-16-15. Higher scores in the respective scales are indicative of greater cognitive restraint (better), uncontrolled (worse), or emotional eating (worse). | Measured at baseline and 12-months after the bariatric surgery |
| Change in diet (3-day food intake record) at 6-months. | 3-day food intake record: individuals will record everything they eat and drink for 3 days. To assess calorie intake and macro nutrients | Measured at baseline and at 6-months after the bariatric surgery |
| Change in diet (3-day food intake record) at 12-months. | 3-day food intake record: individuals will record everything they eat and drink for 3 days. To assess calorie intake and macro nutrients | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in blood levels of Ghrelin at 6-months | Serum levels of Ghrelin. Units of gut hormones include Ghrelin in pg/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in blood levels of Ghrelin at 12-months | Serum levels of Ghrelin. Units of gut hormones include Ghrelin in pg/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in blood levels of glucagon-like peptide (GLP)-1 at 6-months | Serum levels of glucagon-like peptide (GLP)-1. Units of gut hormones include GLP-1 in pmol/L. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in blood levels of glucagon-like peptide (GLP)-1 at 12-months | Serum levels of glucagon-like peptide (GLP)-1. Units of gut hormones include GLP-1 in pmol/L. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in blood levels of Peptide YY at 6-months | Serum levels of peptideYY(PYY). Units of Peptide YY in pg/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in blood levels of Peptide YY at 12-months | Serum levels of peptideYY(PYY). Units of Peptide YY in pg/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in blood levels of insulin at 6-months | Serum levels of insulin. Units of gut hormones include insulin in ulu/L. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in blood levels of insulin at 12-months | Serum levels of insulin. Units of gut hormones include insulin in ulu/L. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in blood levels of leptin at 6-months | Serum levels of leptin. Units of gut hormones include Leptin in ng/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in blood levels of leptin at 12-months | Serum levels of leptin. Units of gut hormones include Leptin in ng/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of these hormones. | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in gut microbiome at 6 months | High-Throughput Microbiome Sequencing for sequencing of the 16S ribosomal RNA. Output sequences are classified as domain, phylum, family and genus to species, depending on the depth of reliable classifier assignments ribosomal RNA (rRNA) gene as the genetic marker to study bacterial phylogeny and taxonomy. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in gut microbiome at 12 months | High-Throughput Microbiome Sequencing for sequencing of the 16S ribosomal RNA. Output sequences are classified as domain, phylum, family and genus to species, depending on the depth of reliable classifier assignments ribosomal RNA (rRNA) gene as the genetic marker to study bacterial phylogeny and taxonomy. | Measured at baseline and at 12-months after the bariatric surgery |
Functional brain images will be obtained using established acquisition protocols for resting state and evoked brain responses |
| Measured at baseline and at 12-months after the bariatric surgery |
| Changes in Inflammatory markers at 6 months | Serum levels of adipokines and inflammatory cytokines. Units include: Adiponectin in pg/ml, Interleukin 1β in pg/ml , Interleukin 6 in pg/ml, Lipopolysaccharide in pg/ml, tumor-necrosis-factor TNF-α in pg/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of adipokines and inflammatory cytokines | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in Inflammatory markers at 12 months | Serum levels of adipokines and inflammatory cytokines. Units include: Adiponectin in pg/ml, Interleukin 1β in pg/ml , Interleukin 6 in pg/ml, Lipopolysaccharide in pg/ml, tumor-necrosis-factor TNF-α in pg/ml. Enzyme-Linked Immunosorbent Assay to measure the levels of adipokines and inflammatory cytokines | Measured at baseline and at 12-months after the bariatric surgery |
| Changes in metabolite concentrations at 6 months. | Differences in blood metabolite concentrations measured by mass spectrometry, comparing metabolite concentrations from obese patients at baseline and after bariatric surgery. | Measured at baseline and at 6-months after the bariatric surgery |
| Changes in metabolite concentrations at 12 months. | Differences in blood metabolite concentrations measured by mass spectrometry, comparing metabolite concentrations from obese patients at baseline and after bariatric surgery. | Measured at baseline and at 12-months after the bariatric surgery |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |